Truist Financial lowered its price objective for Medtronic plc stock.
1 report, 1 independent
Updated Jun 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial lowered its price objective for Medtronic plc stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Medtronic plc
medical device company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- Truist Financial lowered its target price on Carlisle Companies.
- Truist Financial cut its price objective on Core & Main, while a director acquired shares of the firm's stock.
- Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.
- Truist Financial dropped its price objective and set a buy rating, while Jefferies and Royal Bank of Canada also issued rating updates.
- Truist Financial increased its price objective on NETSTREIT (NTST) on September 8, 2026.